Nuvectis Pharma Inc (NVCT)

Finanzdaten der Nuvectis Pharma Inc-Aktie (NVCT)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Research and Development	37.63% 2.66	4.265	4.486	4.262	2.367
Operating Income/Loss	35.97% -4.396	-6.866	-6.158	-5.772	-4.101
Income/Loss From Continuing Operations Before Tax	37.01% -4.171	-6.622	-5.881	-5.708	-4.049
Income/Loss From Continuing Operations After Tax	37.01% -4.171	-6.622	-5.881	-5.708	-4.049
Net Income/Loss	37.01% -4.171	-6.622	-5.881	-5.708	-4.049
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	7,603% 16.56	0.215	16.10	15.18	14.72
Diluted Average Shares	7,603% 16.56	0.215	16.10	15.18	14.72
Basic Earnings Per Share	39.02% -0.25	-0.41	-0.37	-0.38	-0.27
Diluted Earnings Per Share	39.02% -0.25	-0.41	-0.37	-0.38	-0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-